HSP treated in H522 lung cancer cells mediated apoptosis with initiating Fas death receptor/extrinsic pathway, resulting in upregulating Bax, caspase-3, and caspase-9 in a dose-dependent manner [16]. The gene discussed is HSP90B2P; the disease is lung cancer.